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Pluripotent adipose tissue-derived stem cells (hASCs) can diﬀerentiate into various mesodermal cell types such as osteoblasts,
chondroblasts, and myoblasts. We isolated hASCs from subcutaneous adipose tissue during orthopaedic surgery and induced the
osteogenicdiﬀerentiationfor28daysonthreediﬀerentsyntheticscaﬀoldssuchaspolylactide-co-glycolide(PLGA),polylactide-co-
glycolide/hydroxyapatite (PLGA/HA), and trabecular titanium scaﬀolds (Ti6Al4V). Pore size can inﬂuence certain criteria such as
cell attachment, inﬁltration, and vascularization. The aim of this study was to investigate the performance of PLGA and PLGA/HA
scaﬀolds with a higher porosity, ranging between 75% and 84%, with respect to Ti scaﬀolds but with smaller pore size, seeded
with hASCs to develop a model that could be used in the treatment of bone defects and fractures. Osteogenesis was assessed by
ELISA quantitation of extracellular matrix protein expression, von Kossa staining, X-ray microanalysis, and scanning electron
microscopy. The higher amount of protein matrix on the Ti scaﬀold with respect to PLGA and PLGA/HA leads to the conclusion
that not only the type of material but the structure signiﬁcantly aﬀects cell proliferation.
1.Introduction
Stem cells have become the main cell source for tissue repair
because they meet several major cell therapy requirements
that diﬀerentiated primary cells do not meet. They are
deﬁned by their self-renewal, diﬀerentiation capacity, and
they are able to proliferate in culture without losing their
potential to form tissue [1]. The use of stem cells in regen-
erative medicine has received a great deal of interest in recent
years [2], and a promising approach is to promote tissue
regeneration by transplanting tissue engineered constructs
made of a biofactor (cell/gene and/or proteins) grown on
a porous structure known as scaﬀold [3]. The scaﬀold
provides mechanical support and serves as a substrate upon
which cells proliferate and undergo diﬀerentiation. Synthetic
scaﬀolding made of several diﬀerent promiscuous materials
such as titanium, hydroxyapatite, and polymers, has been
used in the treatment of bone defects and fractures for over
100years[4].Partiallyresorbablepolymerssuchaspoly-alfa-
hydroxyacidsarenowbeingintroduced,whichallowfornew
bone growth; these novel polymers have been shaped into
self-reinforcing screws, dowels, rods, and spacers and have
been used with some success in large-bone fracture ﬁxations.
These materials have quite good mechanical characteristics
in terms of stiﬀness and compression resistance. Investiga-
tions into synthetic and natural inorganic ceramic materials
such as HA as coated scaﬀo l dm a t e r i a lh a v eb e e ne m p l o y e d
mostly in bone tissue engineering [5]. This is because these
ceramics resemble the natural inorganic component of bone
and have osteoconductive properties [6]. Recent develop-
ments have led to the interest in the potential of porous HA
as synthetic bone graft [7]. HA exhibits a strong propensity2 Bioinorganic Chemistry and Applications
Table 1: Apparent density, porosity, and pore size of PLGA and
PLGA/HAP scaﬀolds.
Scaﬀold
type
Apparent
density (g/L)a Porosity (%)a Pore size (μm)b
PLGA 0.12 ± 0.03 83.77 ± 0.62 200–350
PLGA/HA 0.19 ± 0.01 75.44 ± 0.4 200–300
aDetermined by Displacement method (solvent - Ethanol); bDetermined
by SEM.
for attracting osteoblasts but possesses a low resorption rate
in vivo and is brittle, especially in highly porous forms. In
order to alleviate some of these inherent issues, while still
maintaining its beneﬁts, HA has been combined with several
natural and synthetic polymers such as PLGA to produce
composite scaﬀolds. The addition of biodegradable PLGA to
HA would allow for better manipulation, biocompatibility,
and control over both the macro- and microstructure in
shaping composites to ﬁt bone defects. In addition, PLGA
could be used as a binder for HA to reduce brittleness of
ceramics. PLGA/HA composites are promising materials for
bone grafts and have been extensively investigated [8].
Polymeric 3D scaﬀoldshaveseveraladvantagessincethey
permit a precise selection of the material and consequently
of the nanostructure and the architecture of scaﬀolds. More-
over, they have been widely studied in the last years, mainly
due to their good biocompatibility (their use also had its ori-
gin and has been consolidated in the pharmaceutical ﬁeld),
their chemical versatility, and good biological performances;
they also do not imply danger of immunogenic reactions
or possibility of disease transmission. They biodegrade by
random chain scission generating monomers of lactic and
glycolic acid that are eliminated through the metabolic
pathways. The intrinsic properties of the raw material play a
strategic role in the production, structure, and morphology
and, consequently, in the functional performances of the
polymer scaﬀold [9]. To act as an artiﬁcial ECM, the
structure and the surface morphology of the scaﬀolds have
to meet general requirements speciﬁc for the targeted tissue:
(i) interconnected pores to ensure cells growth and nutrients
and metabolic waste transport ﬂow; (ii) three-dimensional
architecture; (iii) suitable mechanical properties; (iv) suit-
able surface chemistry; (v) controllable biodegradation and
bioresorbability[10].Thescaﬀoldshapeshouldalsofacilitate
cell seeding and attachment and promote cell proliferation
and diﬀerentiation [11]. Moreover, the bioresorbable scaf-
fold should present mechanical properties (strength and
stiﬀness) equivalent to those of the host tissue until the
bioresorbable scaﬀold matrix is substituted by the new tissue
[12].
Trabecular titanium is an inert non-biodegradable mate-
rialwithanexcellentbiocompatibility[2];ithasbeenutilized
predominantly for long bone defects because of its excellent
compressive strength. Not only does the scaﬀold shape
provideasubstrateonwhichbonecangrow,butalsoscaﬀold
geometry inﬂuences critical environmental properties such
as the feasibility of vascular ingrowth and resistance to
ﬁbrous tissue inﬁltration [4]. Porosity is a measure of the
open pore volume within the matrix, often called the void
fraction. Open pores have cellular access on both sides and
allow for liquid ﬂow and transport of nutrients through the
porous matrix [13].
Pore size is referred to the distance between solid sections
of the porous matrix; it is typically reported as the diameter
of circular pores or the major axis for noncircular pores.
Pore size aﬀects cell binding, migration depth of cellular in-
growth, cell morphology, and phenotypic expression [14].
Scaﬀolds with mean pore size ranging from 20μmt o
1500μm have been used in bone tissue engineering applica-
tions [15]. By facilitating capillary formation, pores greater
than 300μm lead to direct osteogenesis, while pores smaller
than 300μm can encourage osteochondral ossiﬁcation [15,
16].
Pore size not only aﬀects cell growth but also aﬀects scaf-
fold properties; for example, the elasticity of microporous
scaﬀold increases as the number of pores within the scaﬀold
increases [13, 17]. The pore architecture of polymer scaﬀold
resultedtobebetween300and350μm,porosity65–70%;the
average diameter of the cell pores used in Ti6Al4V construct
is 640μm, and the structure has an average porosity of 65%.
Bone tissue engineering techniques based on autogenous
cell/tissue transplantation would eliminate problems of
donor scarcity, supply limitation, pathogen transfer, and
immune infection [18].
The aim of this study was to evaluate the adhesion and
osteogenic diﬀerentiation of hASCs grown on polylactide-
co-glycolide (PLGA), polylactide-co-glycolide/hydroxyapa-
tite (PLGA/HA), and on trabecular titanium scaﬀolds (Ti6A
l4V) by comparing the analysis of indicators of osteoblastic
phenotype such as cell adhesion on diﬀerent scaﬀolds, the
extraction and measurement of type-I collagen (COL I) and
alkaline phosphatase (ALP). Scanning Electron Microscopy
(SEM) of all types of scaﬀolds before and after colonization
with cells, von Kossa staining, and X-ray microanalysis
were performed to detect the calciﬁed extracellular matrix
production.
2.MaterialsandMethods
2.1. Materials. LGA polymer (PLGA 8515 DLG 7E, Mw
120kDa, Mn 97kDa) was purchased from Lakeshore Bio-
materials,Birmingham(USA).Salt(NaCl,Mw58.443g/mol,
solubility in water 36g/100mL at 20◦C) and 1,4-Dioxane,
used for the preparation of PLGA scaﬀolds, were obtained
from Carlo Erba, Milan (Italy). Hydroxyapatite (HA) nano-
powder <200nm was purchased from Sigma-Aldrich. The
water used in the preparation of scaﬀold was distilled and
ﬁltered through 0.22μm Millipore membrane ﬁlters (Milli-
pore Corporation, Massachusett, USA). Unless speciﬁed, all
other solvents and reagents were of analytical grade.
2.2. Preparation and Characterization of PLGA, PLGA/HA
Scaﬀolds. PLGA and PLGA/HA scaﬀolds were prepared by
solvent/casting particulate leaching method as explained in
ap r e v i o u sw o r k[ 19]. Brieﬂy, the scaﬀold preparation was
performed as follows: 700μL of PLGA solution (15% w/vBioinorganic Chemistry and Applications 3
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Figure 1: Images of PLGA (a) and PLGA/HA (b) scaﬀolds obtained using the porogen particle leaching method as reported in “Materials
and methods”; (c) image of trabecular titanium scaﬀold (Ti6Al4V).
in 1,4-Dioxane) or of a suspension of 5% HA in the PLGA
were cast drop by drop into Teﬂon moulds (cylindrical
vials with a diameter of 10mm) ﬁlled with 700mg of NaCl
porogen particles with 600–1180μm diameter. The mould
containing the porogen and the polymer solution was ﬁrst
maintained at room temperature (RT) overnight to permit
the diﬀusion of the polymer solution through the porogen
particles, and then it was placed at −25◦C for 24 hours. The
frozen porogen/polymer mixture was freeze-dried at −50◦C
for 12 hours to completely remove the solvent. The scaﬀolds
were dialyzed in water (200mL) at RT for 21 days to remove
the porogen particles. The water was changed three times a
day for the ﬁrst week and then once a week. After dialysis the
scaﬀoldswerefreeze-driedat −50◦Covernight.Theprepared
scaﬀolds were stored in a dessicator at −25◦C. The scaﬀolds
have aheight of 6mm and adiameter of 12mm (Figures1(a)
and 1(b)). The same preparation process has been used to
obtainstripsamplesof5×5×15mmthatunderwenttension
tests.
2.3. Characterization of PLGA, PLGA/HA Scaﬀolds
2.3.1. Density and Porosity Determination. The density and
porosityvaluesofthePLGAandPLGA/HApolymerscaﬀolds
weremeasuredusingamodiﬁedliquiddisplacementmethod
[20] with ethanol as the displacement liquid.
A weighted polymer scaﬀold (W) was immersed in a
graduated cylinder containing a known volume (V1)o f
ethanol. The sample was kept in the nonsolvent for 10min,
and then a set of evacuation-repressurization cycles was con-
ducted to force the ethanol into the pore structure.
Cyclingwascontinueduntilnoairbubbleswereobserved
leaving the scaﬀold surface. The total volume of the ethanol
and ethanol-soaked scaﬀo l dw a st h e nr e c o r d e da sV 2.T h e
volume diﬀerence, (V2−V1), represented the volume of
the scaﬀold skeleton. The ethanol-soaked scaﬀold was then
removed from the cylinder and the residual ethanol volume
wasrecordedasV3.Thev olume(V 1−V3),thatis,theethanol
volume retained in the porous scaﬀold, was deﬁned as the
pore volume of the scaﬀold. The total volume of the scaﬀold
was calculated as follows:
V = (V2 −V1)+ (V1 − V3) = V2 − V3. (1)
The density of the scaﬀold (d) was expressed as
d = W/(V2 −V3). (2)
And the porosity of the scaﬀold (ε) expressed as percentage
(%) was calculated by
ε (%) = (V1 − V3)/(V2 −V3) ∗100. (3)
The density and porosity determined in triplicate (n = 3)
and expressed as mean ± standard deviation are reported in
Table 1.
2.3.2. Mechanical Tests. Cylindrical samples (∼6mm diam-
eter × 12mm height) underwent compression tests whereas
strip samples (∼5 × 5 × 15mm) underwent tensile tests.
Allthemechanicaltestswereperformedusinganelectro-
magnetic testing machine (Enduratec ELF3200, Enduratec-
Bose, Minnetonka, MN, USA), equipped with a load cell of
220N for evaluation of compression and tensile resistance,
under displacement control, at a velocity of 0.1mm/s.
Diﬀerent grips were used with the machine depending
on the test conﬁguration, that is, compression or tension.
Compression test has been carried out by application on
the cylindrical scaﬀolds, of same loadings with opposite
directions both directed towards the interior part of the
scaﬀold. This allows the uniform distribution of forces, on
an orthogonal plan, inside the scaﬀold structure. In the
presence of an elastic material, this determines shortening of
the matrix in its axial direction and widening of the matrix
in its radial direction.
The results of compression tests and tensile tests are
reported in Table 2 as elastic modulus (Ec1,E c2,E c3,a n dE t)
extracted from the linear regions of the stress strain curves.4 Bioinorganic Chemistry and Applications
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Figure 2: Phenotypic characterization of hASCs: CD105, 73, and 90 mesenchymal stem cells markers are positive; CD34 and 45
haematopoietic stem cells markers are negative.Bioinorganic Chemistry and Applications 5
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Figure 3: (a) hASCs after the 3rd passage in control medium show a ﬁbroblast-like shape; (b) hASCs in osteogenic medium after 28 days
show a more spherical shape if compared to the undiﬀerentiated cells (Toluidine blue). Mag. 10x.
L = SE1 EHT = 20kV WD = 21mm MAG =× 11 Photo = 3
2mm
(a)
L = SE1 EHT = 15kV WD = 16mm MAG =× 260 Photo = 32
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Figure 4: Scanning electron microscopic images of unseeded titanium scaﬀolds (a) and seeded titanium scaﬀolds (Ti6Al4V) with hASCs
in osteogenic medium (b). Panel A shows the innovative multi-planar hexagonal structure of the scaﬀold imitating the structure of the
trabecular bone, bar = 2mm. In Panel B, cells appear to cover the surface of the trabecular scaﬀold uniformly and completely, bar =100μm;
(c) Extracellular matrix between pores, bar = 20μm.
2.4.TitaniumScaﬀolds. TrabecularTitaniumscaﬀolds(Ti6Al
4V) were provided by manufacturer Lima-Lto S.p.A. (Lima,
Villanova di San Daniele del Friuli, Italy). An innovative
multiplanar hexagonal cell structure imitating the cell
structure of the trabecular bone was developed, and its
morphology and dimension have been optimized to improve
vascularization and therefore maximize osteointegration.
Previous studies have shown that the minimum pore
size to improve osteointegration is 300μm. Moreover, cells
grew at a signiﬁcantly faster rate into drill channels having
a diameter of 600μm than channels of diameters of 300,
400, 500, and 1000μm[ 21]. The average diameter of the cell
pores used in Ti6Al4V construct is 640μm; the structure has
an average porosity of 65% [22]. The Trabecular Titanium
scaﬀolds (Ti) used have a height of 6mm and a diameter
of 12mm (Figure 1(c) ); the value of elastic modulus of
trabecular Titanium has been reported by Marin et al. [22].
2.5. Human Adipose Derived Stem Cells (hASCs). Stem cells
were prepared from subcutaneous adipose tissue obtained
from healthy donors during orthopaedic surgery. Informed
consent was obtained before surgical intervention. Brieﬂy,
the tissue was ﬁnely minced and then incubated in
digestion buﬀer (0.01% collagenase type II in DMEM
F12-HAM medium supplemented with 10% FBS, 100 U
penicillin/streptomycin, amphotericin) for 1h at 37◦C while
vigorously shaking. At the end of the incubation time, ﬁve
volumes of DMEM F12-HAM were added to neutralize
collagenase, and the suspension was centrifuged at 1200rpm
for 10min. The resulting pellet, containing hASCs, was sus-
pended in DMEM F12-HAM supplemented with 10% FBS,
100U penicillin/streptomycin, and amphotericin (control
medium, CM). The hASCs were initially cultured in CM up
to 95% conﬂuence in a humidiﬁed atmosphere of 95% air
with 5% CO2 at 37◦C. The adherent cells were trypsinized,
and 1×105 hASCs per 100mm2 were seeded in ﬂasks. These
passages were repeated three times.
2.6. Flow Cytometric Surface Markers Analysis. hASCs were
phenotypically characterized by ﬂow-cytometry; ﬂuorescein
isothiocyanate (FITC) or phycoerythrin (PE)-conjugated
monoclonal antibodies, speciﬁc for CD45, CD34, CD90 (BD
PharMingen,SanDiego,Calif,USA),CD73,CD105(Serotec,
Kidlington, Oxford, UK), were used.
Appropriate, isotype-matched, nonreactive ﬂuorochrome-
conjugated antibodies were employed as controls. An anal-
ysis of cell populations was performed by means of direct
immunoﬂuorescence with an FACScalibur ﬂow cytometer
(BD PharMingen), and data was calculated using CellQuest
software (BD Pharmingen).6 Bioinorganic Chemistry and Applications
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Figure 5: Scanning electron microscopic images of unseeded PLGA scaﬀold (a), bar = 500μm and seeded PLGA scaﬀold (b and c) with
hASCs in osteogenic medium for 28 days. Panel b shows cells embedded in their extracellular matrix over the scaﬀold surface bar = 100μm.
Panel c shows round cells bar = 100μm.
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Figure 6: Scanning electron microscopic images of unseeded PLGA/HA scaﬀold (a), bar = 200μm and seeded PLGA/HA scaﬀolds (b and
c) with hASCs in osteogenic medium for 28 days. In panel B, cells appear have a round morphology, bar = 100μm. Panel C, at greater
magniﬁcation, clusters of cells embedded in their matrix and inside the pores of the scaﬀold, bar = 20μm.
2.7. Cell Seeding and Culture Conditions. At conﬂuence, the
cells were trypsinized and inoculated onto each scaﬀold as
follo ws:adr opof50μLcontaining5×105 cells was placed on
the top of the scaﬀolds which were placed in 24 wells (Costar,
Corning Inc., NY, USA) and allowed to be adsorbed by the
porous substrates for 2 hours before the CM was added. For
osteogenic diﬀerentiation, 5 cell/scaﬀold constructs for each
type of scaﬀold were switched over to osteogenic medium
(OM) (DMEM F12-HAM containing 15% FBS, 10mM
beta-glycerophosphate, 100nM dexamethasone, 0.05mM
ascorbic acid, antibiotics, and amphotericin). The scaﬀolds
were maintained in OM for 28 days.
3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium
bromide test.
To evaluate the mitochondrial activity of the seeded cells,
that is, the cell viability on the PLGA, PLGA/HA, and 3D
Ti scaﬀolds during the culture period, a test with 3-(4,
5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) (Sigma-Aldrich) was performed on days 1, 3, 14, and
28 (end of the culture period). The culture medium was
replaced with a 0.5mg/mL solution of MTT in phosphate-
buﬀered saline (PBS) (137mM NaCl, 2.7mM KCl, 4.3mM
Na2HPO4,1 . 4m MK H 2PO4, pH 7.4), and the cell cultures
were incubated for 4hs. Viable cells are able to reduce MTT
into formazan crystals. After removing the MTT solution,
to solubilize the formazan products, 500μL of dimethyl
sulfoxide (Sigma-Aldrich) were added, and the well plate
containing the cultured 3D scaﬀolds was agitated for 20min
on a shaker. Aliquots of 200μL were sampled, and the
related absorbance values were measured at 570nm with
a microplate reader (BioRad Laboratories, Hercules, Calif,
USA). A standard curve of cell viability was used to express
the results as percentage.
2.8. DNA Content. At the end of incubation (28 days), cells
present on the scaﬀolds were lysed by a freeze-thaw method
insteriledeionizeddistilledwater.ThereleasedDNAcontent
was evaluated with a ﬂuorometric DNA quantiﬁcation
kit (PicoGreen, Molecular Probes, Eugene, Ore, USA). A
DNA standard curve, obtained from a known amount of
osteoblasts, was used to express the results as cell number per
scaﬀold.
2.9. Scanning Electron Microscopy (SEM). SEM was per-
formed on PLGA, PLGA/HA and on trabecular titanium
scaﬀolds before and after 28 days of incubation with hASCs
cells. The scaﬀolds were ﬁxed in glutaraldehyde 2.5% and
Na-cacodylate buﬀer at pH 7.4 for about 2hrs and then
washed with Na-cacodylate buﬀer for 30 minutes. TheBioinorganic Chemistry and Applications 7
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Figure 7: von Kossa staining of hASCs grown in osteogenic medium for 28 days in a culture monolayer. (a) Negative control, (b) positive
sample; the secreted calciﬁed extracellular matrix are shown as black nodules Mag. 20x. (c) X-ray microanalysis performed on trabecular
titanium,(d)PLGA scaﬀolds,(e) PLGA/HA scaﬀolds seeded with hASCsin osteogenic medium for 28 days. Calcium and Phosphatum peaks
were detected, inferring that hydroxyapatite was formed.
dehydration process was performed using an increasing
ethanol concentration (from 50% to 100%). Samples were
then submitted to critical point drying with CO2,m o u n t e d
on aluminium stubs, and gold sputtered (degree of purity
99.9%)underargonatmospheretoallowadequategoldcoat-
ing of the internal surface of porous structure (Sputter coater
BALZER). Observations and micrographs were performed
with an SEM Cambridge Stereoscan, operating at 20kV.
2.9.1. Set of Puriﬁed Proteins and Antibodies for ELISA Assay.
Type-I collagen was puriﬁed as described previously [23,
24]; osteocalcin was acquired from Biomedical Technologies
(Stoughton, Mass, USA), and alkaline phosphatase was
purchased from Sigma-Aldrich, Inc. Dr. Larry W. Fisher
(http://csdb.nidcr.nih.gov/csdb/antisera.htm, National Insti-
tutes of Health, Bethesda, Md, USA) provided us with the
rabbit polyclonal antitype-I collagen, anti-osteocalcin, and
antialkaline phosphatase.
2.9.2. Extraction of the Extracellular Matrix Proteins from the
Cultured Scaﬀolds and ELISA Assay. On days 3 and 28, in
order to evaluate the amount of the extracellular matrix
constituents through the scaﬀolds surface, the scaﬀolds were
washed extensively with sterile PBS in order to remove the
culture medium and then incubated for 24hs at 37◦Cw i t h
1mL of sterile sample buﬀer (20mM Tris-HCl, 4M GuHCl,
10mM EDTA, 0,066% [w/v] SDS, pH 8.0). At the end of the
incubation period, the sample buﬀer aliquots were removed,8 Bioinorganic Chemistry and Applications
and then the 3D Ti, PLGA, and PLGA/HA scaﬀolds were
centrifuged at 4000rpm for 15min in order to collect the
sample buﬀer entrapped inside the pores. The total protein
concentration in the culture system was evaluated by the
BCAProteinAssayKit(PierceBiotechnology,Inc.,Rockford,
Ill, USA). The total protein concentration was 0,573 ±
0,021mg/mL on Ti scaﬀolds, 0,120 ± 0,010mg/mL on PLGA
scaﬀolds, and 0,414 ± 0,018mg/mL on PLGA/HA scaﬀolds.
After matrix extraction, the scaﬀolds were incubated, once
again, for 24hs at 37◦C with 1mL of sterile sample buﬀer,
and no protein content was detected. Calibration curves
to measure type-I collagen and alkaline phosphatase were
performed. Microtiter wells were coated with increasing
concentrations of each puriﬁed protein, from 10ng to 2μg,
in coating buﬀer (50mM Na2CO3, pH = 9.5) overnight
at 4◦C. Some of the wells were coated with bovine serum
albumin (BSA) as a negative control. In order to measure
the extracellular matrix amount of each protein by an
ELISA assay, microtiter wells were coated, overnight at 4◦C,
with 100μL of the previously extracted extracellular matrix
(20μg/mL in coating buﬀer). After three washes with PBST
(PBS containing 0.1% [v/v] Tween 20), the wells were
blocked by incubating with 200μL of PBS containing 2%
(w/v) BSA for 2hs at 22◦C. The wells were subsequently
incubated for 1.5hs at 22◦C with 100μL of the L. Fisher’s
anti-type-I collagen and anti-alkaline phosphatase rabbit
polyclonal antisera (1:500 dilution in 1% BSA). After
washing, the wells were incubated for 1 h at 22◦Cw i t h
100μL of HRP-conjugated goat antirabbit IgG (1:1000
dilution in 1% BSA). The wells were ﬁnally incubated with
100μL of substrate solution (phosphate-citrate buﬀer with
o-phenylenediamine dihydrochloride). The colour reaction
wasstoppedwith100μLof0.5MH 2SO4,andtheabsorbance
values were measured at 490nm with a microplate reader
(BioRad Laboratories). An underestimation of absolute
proteindepositionispossiblebecausethesamplebuﬀer,used
for matrix extraction, contained sodium dodecyl sulphate,
which may have interfered with protein adsorption during
ELISAassay.Theamountofextracellularmatrixconstituents
throughout the scaﬀolds was expressed as pg/(cell × scaf-
fold).
2.9.3. Evaluation of Calcium Deposition. Monolayers of cells
grown on culture plates were rinsed with PBS and ﬁxed
in 4% paraformaldehyde for 1h at room temperature. The
cells were then incubated in 5% silver nitrate for 30 minutes
in the dark, rinsed with distilled water, and exposed to
ultravioletlightfor1h.Secretedcalciﬁedextracellularmatrix
was observed as black nodules.
X-ray microanalysis of the samples was run to detect the
presence of Ca, P and their location within the scaﬀolds.
The images were obtained with a Cambridge Stereoscan 250,
Scanning Electron Microscope.
2.10. Statistical Analysis. Data are presented as mean ±
SD. Statistical analyses were performed using the one-way
ANOVA method followed by Newman-Keuls’Q test (Graph-
Pad Prism 4.0).
3. Results
3.1. PLGA, PLGA/HA Scaﬀolds Characterization. Table 1
reports the porosity and apparent density of the polymeric
scaﬀolds. The PLGA scaﬀolds resulted to have signiﬁcantly
higher porosity than PLGA/HA scaﬀo l d s .T h i si sp r o b a b l y
due to the presence of HA that is mixed as nanosize powder
to the polymeric solution during the scaﬀold preparation
process. The pore architecture of polymer scaﬀold examined
by scanning electron microscopy shows the presence of
interconnected pores whose diameter is between 200 and
350μm. As shown in Table 1, the presence of HA reduces
both porosity and pore size of scaﬀolds.
Aslongasmechanicalpropertiesareconcerned,compres-
sion up to 50% of the initial length resulted in plastic defor-
mation without failure. Conversely, tension tests resulted in
specimen failure although the strain level for failure was
variable depending on the scaﬀold.
Compression stress-strain curves of PLGA scaﬀolds
showed three linear regions. Compression stress-strain
curves of PLGA+HA showed two linear regions. All tension
tests showed one linear region before yield and failure.
Compression and tension moduli as derived from all the
linear regions are reported in Table 2. The presence of HA
in the composite scaﬀolds does not seem to improve the
compression properties of polymeric scaﬀolds, while tensile
properties are improved by addition of HA to the polymeric
structure.
3.2. Flow Cytometry. The surface phenotype of hASCs was
analyzed by ﬂow cytometry at passage 3 (P3), and resulted to
be in agreement with previous reports [25, 26]. In particular,
by the third passage, contamination with hematopoietic cells
was no longer detectable, and more than 98% of the cells
expressed the MSC typical surface marker pattern. In detail,
hASCs were positive for CD73, CD90, and CD105 surface
antigensandnegativeforCD34andCD45molecules[27,28]
(Figure 2).
3.3. Monolayer Culture of hASCs. In a monolayer culture
prior to osteogenic induction, hASCs showed an elon-
gated, ﬁbroblastic appearance (Figure 3(a)). After 28 days
of cell culture in OM, the hASC morphology diﬀerentiated
to osteoblasts, changing into a rounder, cuboidal shape
(Figure 3(b)). Furthermore, mineralization was determined
qualitatively for calcium deposition by von Kossa staining
(Figure 7(a)); positive staining was detected by the appear-
ance of black nodules (Figure 7(b)).
3.4. Cell Morphology. Cells cultured on the 3D Ti, PLGA,
and PLGA/HA scaﬀolds were observed by SEM (Figures 4,
5 and 6). Figures 4, 5,a n d6 are each a representative image
of 28 days of cell culture in OM showing adherence of cells
to the surface on the 3 types of scaﬀolds. In particular, the
cells homogeneously covered the surface and spanned to the
neighbouring ﬁbers on the 3D Ti scaﬀold (Figure 4(b))a n d
PLGAscaﬀolds(Figure 5(b)).Athighermagniﬁcationonthe
Ti scaﬀold (Figure 4(c)) cells are embedded within a denseBioinorganic Chemistry and Applications 9
Table 2: Compression and tensile properties of PLGA and PLGA/HA scaﬀolds.
Compression test Tensile test
Scaﬀold type Ec1 (Mpa) Ec2 (Mpa) Ec3 (Mpa) Et (Mpa) Ts (Mpa) UTS (Mpa)
PLGA 1.66 ± 0.76 0.88 ± 0.17 3.07 ± 0.28 2.88 ± 1.44 0.13 ± 0.03 0.15 ± 0.03
PLGA/HA 4.76 ± 2.32 1.07 ± 0.16 — 15.68 ± 4.41 0.17 ± 0.04 0.35 ± 0.12
Table 3: Normalized amount of the extracellular matrix proteins secreted and deposited throughout PLGA, PLGA/HA and Ti scaﬀolds
cultured in osteogenic medium for 28 days.
Type of scaﬀold Alkaline phosphatase Type I collagen (pg/cell per scaﬀold) Osteocalcin
PLGA 2.60 ± 0.05 5.18 ± 0.1 2.00 ± 0.04
PLGA/HA 2.91 ± 0.01 8.80 ± 0.2 3.00 ± 0.2
Trabecular Ti 4.00
∗± 0.13 26.50
∗± 0.15 6.00 ± 0.07
∗P ≤ .05 versus PLGA and PLGA/HA scaﬀolds.
layer of ECM that also forms a bridge between the porous
structures.
On PLGA sample, cellular processes covered almost the
entire scaﬀold surface in an abundant ECM (Figure 5(c)).
On the PLGA/HA, some cells were present on the surface
(Figure 6(b)) ,b u tt h em a j o r i t yo fc e l l sw e r ec o m p l e t e l y
embedded in ECM, ﬁlling the porous structure, as can be
observed at higher magniﬁcation (Figure 6(c)).
To evaluate the cell viability on the PLGA, PLGA/HA,
a n dT is c a ﬀolds during the culture period, an MTT test was
performed. On days 1, 3, 14, and at the end of the culture
period, the average cell viability was in the 86–91% range
with no statistically signiﬁcant diﬀerence in the cell viability
(P>. 05) among all types of scaﬀold at each culture period.
3.5. Cell Attachment. To assess whether the diﬀerent types
of scaﬀolds could inﬂuence the initial cell attachment and
thustheECMdeposition,thenumberofosteoblastsattached
to every type of scaﬀold was detected earlier on days 1
and 3 and later on day 28. The longer incubation time was
chosen to allow the in vitro cell production of detectable
bone proteins. The percentage of cell attachment was about
20% ± 2.5% (on day 1) and 35% ± 2.2% (on day 3) for all
types of scaﬀolds, showing no signiﬁcant diﬀerence (P>
.05). After 28 days of cell culture, a signiﬁcantly consistent
increase in the measurement of DNA content was detected
on the titanium 3D scaﬀo l dw h e nc o m p a r e dt oP L G Aa n d
PLGA/HA scaﬀolds. On the Ti, the cell number per scaﬀold
rose to 4,5 × 105± 0,4 × 102, whereas on PLGA scaﬀolds it
reached 3,8 ×105 ±0,2×102 (P<. 05). The number of cells
attached to PLGA/HA was around 3,7 ×105 ±0,15 ×102.
3.6. Characterization of the Calciﬁed ECM Deposition. To
evaluate the amount of the ECM constituents produced
throughout PLGA, PLGA/HA, and Ti scaﬀolds, an ECM
extraction was performed on days 3 and 28 of incubation.
Unfortunately, on day 3 even if the total protein content
was determined, the levels of the speciﬁc bone proteins
were too low to be detected in all types of scaﬀolds. At
the end of the culture period the deposition of ALP, type-
I collagen, and osteocalcin throughout the Ti scaﬀolds was
signiﬁcantly higher (P<. 05) in comparison with the culture
grown on the PLGA and PLGA/HA scaﬀolds (Table 3). The
enhancement of protein deposition was particularly marked
for type I collagen, which was ﬁvefold and threefold greater
when compared with the PLGA and PLGA/HA samples,
respectively (Table 3). The level of the ALP deposition was
almost twofold higher on the Ti scaﬀolds with respect to
PLGA and PLGA/HA; the deposition of osteocalcin, which
is known to be a mineralization marker, was signiﬁcantly
lower on PLGA and PLGA/HA samples when compared to
Ti scaﬀolds.
The qualitative evaluation of the calcium deposition was
performed by X-ray microanalysis on cells grown on PLGA,
PLGA/HA, and Titanium scaﬀold (Figures 7(c), 7(d), 7(e))
that revealed an increased presence of calcium and phos-
phorus inferring that calcium phosphate (hydroxyapatite)
had been deposited. No signiﬁcant diﬀerences among the
scaﬀolds were observed.
4. Discussion
In this paper, we studied the adhesion and the diﬀerentiation
of hASCs grown in osteogenic medium for 28 days on
PLGA, PLGA/HA, and Trabecular Titanium scaﬀolds. The
biocompatibility of the biomaterial is very closely related
to the cell behaviour in contact with the biomaterial and
particularly to cell adhesion on the biomaterial surface [3,
29]. The material surface can inﬂuence cell reaction through
changes in the cytoskeleton, a network of protein ﬁlaments
extending through the cell cytoplasm within eukaryotic cells
[29]. It is known that cell behaviour and interaction with
a biomaterial surface are dependent on properties such as
topography, surface charges, and chemistry [30, 31].
The porous three-dimensional scaﬀold acts as a tempo-
rary ECM for the physical support of cells, their adhesion,
growth, and diﬀerentiation [32–34], and the adequate sizing
o fp o r e si se s s e n t i a li ns c a ﬀold design for tissue engineering,
providing suﬃcient space for cell migration, adhesion,
proliferation, and the ingrowth of new bone tissue [35, 36].
The advantage of porous materials is their ability to provide
biological anchorage for the surrounding bony tissue via
ingrowth of mineralized tissue into the pore space [37].10 Bioinorganic Chemistry and Applications
A porous-surfaced implant could improve early implant
stability and resistance of mechanical removal [38]. The high
porosity (65–70%) and the broad pores (diameter of 350 to
550μm) should be suﬃcient to enable an ample nutrition
supply inside the scaﬀold. The trabecular Ti scaﬀolds used
in this work have an average porosity of 65% and a pore
diameter of 640μm, which is currently being used clinically
as a bone implant. The PLGA and PLGA/HA scaﬀolds have
higher porosity than the Ti scaﬀolds, ranging between 75%
and 84%, but smaller pore sizes, averaging 300μm; these
parameters can aﬀect cell growth and proliferation. If the
pores are too small, cell migration is limited, resulting in
the formation of a cellular capsule around the edges of the
scaﬀold; this in turn can limit diﬀusion of nutrients resulting
in necrotic regions within the construct. Conversely, if pores
are too large there is a decrease in surface area limiting
cell adhesion [9, 39]. By facilitating capillary formation,
pores greater than 300μm lead to direct osteogenesis while
pores smaller than 300μm can encourage osteochondral
ossiﬁcation [12, 24, 27].
In a previous study O’Brien et al. [40] showed that
speciﬁc surface area decreases with increasing pore size; it
is hypothesized that the eﬀect of speciﬁc surface area is
due to the ligand density available for integrin-binding after
initial seeding [15]. Moreover PLGA scaﬀo l dp o r es i z eh a s
been selected as a function of scaﬀold mechanical properties:
large pore size makes the scaﬀold more fragile and decrease
surface density. Thus the scaﬀo l dp o r es i z es e l e c t e di sag o o d
compromise between their mechanical resistance and their
biocompatible properties. This concept is not applicable to
Titanium scaﬀolds because their mechanical properties are
not sensibly related to scaﬀold pore size. For this material the
pore size selected seems to be to most suitable to improve
osteointegration [39].
Scaﬀolds with smaller pores have a greater surface area
which provides increased sites for initial cellular attachment
postseeding;scaﬀoldswiththelargestporesfacilitateahigher
rate of scaﬀold inﬁltration with even cell distribution. Cells
migrateintothecentreofthescaﬀoldresultingintheabsence
of cell aggregation; this demonstrates that cell migration
increases with increasing pore size [41]. It is important
to identify the upper limits in pore sizes as large pores
may compromise the mechanical properties of the scaﬀolds
by increasing void volume [12]. Therefore maintaining a
balance between the optimal pore size for cell migration and
speciﬁc surface area for cell attachment is essential [16].
The mechanical properties of the two materials are
very diﬀerent. As reported in the literature, the mechanical
properties of a scaﬀold should resemble, the closest as
possible those of bones.
Elastic modulus of cortical bone (long bones) ranges
between 17 and 20GPa for longitudinal axis, 6 and 13GPa
for transversal axis; elastic modulus of spongious bone
rangesbetween50–100MPa[42].Lookingatthesereferences
parameters, the values of elastic modulus for Titanium are
more close to those of cortical bone; this makes Titanium
a good material for repair of long bones fractures. The
evaluated polymer scaﬀolds have values of elastic modulus
lower than those of both bones and titanium. Nevertheless,
addition of HA to PLGA greatly improves the mechanical
properties of polymeric scaﬀolds, above all as tensile prop-
erties.
The hASCs isolated from the subcutaneous adipose
tissue of the hip contained a distinct cell population which
expressed the stem cell markers CD73, CD90, and CD105;
these results are consistent with others [17–20].
Morphological investigation with SEM demonstrated
that hASCs grown in osteogenic medium for 28 days pro-
duced an abundant and homogeneous extracellular matrix
(Figures 4, 5,a n d6) containing proteins such as alkaline
phosphatase and type I collagen (Table 3) extracted from the
scaﬀold/cellsconstruct.Theamountofalkalinephosphatase,
an extracellular protein necessary for matrix mineralization
[35, 36], extracted from the Ti scaﬀold/cells construct was
twofold higher on Ti scaﬀolds with respect to PLGA and
PLGA/HA scaﬀolds. Deposition of type I collagen that
represents 90% of the bone matrix and osteocalcin, an
extracellular protein necessary for matrix mineralization,
was highly decreased on PLGA and PLGA/HA scaﬀolds if
compared to Ti scaﬀolds. Diﬀerently to Ti samples, collagen
reduction was much higher on PLGA (5-fold) with respect
to PLGA/HA (3-fold) scaﬀolds whereas for osteocalcin was
3 fold on PLGA and 2-fold on PLGA/HA. These results
are quite interesting showing an order in the biomaterials
predilection for cells adhesion and proliferation: Ti >
PLGA/HA > PLGA.
Bone type-I collagen, designated [alfa1(I)2alfa2], com-
prises 85–90% of the total organic bone matrix, and its
synthesis is upregulated at the proliferation stage and down-
regulated during the subsequent stages [43–45]. The deposi-
tion of a larger amount of type-1 collagen and osteocalcin on
Ti scaﬀo l di nc o m p a r i s o nt oP L G Aa n dP L G A / H As c a ﬀolds
may suggest that the type of scaﬀold could favour osteoblast
proliferation and diﬀerentiation and promote bone ECM
deposition.
Although no reports have evaluated which scaﬀold is
o p t i m a lf o rA S Cc u l t u r ea n dd i ﬀerentiation, we used a PLGA
scaﬀold because of its stability and utility for bone tissue
engineering by surface modiﬁcation.
Theextracellularmatrixcalciﬁcationwasconﬁrmedwith
von Kossa staining after 28 days of diﬀerentiation in mono-
layer and by X-ray microanalysis on scaﬀolds.
The results achieved demonstrate that PLGA and PLGA/
HA are biocompatible and that scaﬀolds made of these poly-
mers are suitable for cell proliferation; the higher amount
o fp r o t e i nm a t r i xo nT is c a ﬀold with respect to the PLGA
and PLGA/HA scaﬀolds leads to conclude that not only the
type of material but the structure signiﬁcantly aﬀects cell
proliferation. The structural parameters for scaﬀold to be
used in bone repair application resulted to be those shown
by Trabecular Titanium scaﬀold. Since addition of HA to
polymer improves the scaﬀold mechanical properties keep-
ing their biocompatibility, the composite scaﬀolds should be
further investigated.
Despite the fact that material science technology has
resulted in clear improvements in the ﬁeld of bone sub-
stitution medicine, no adequate bone substitute has been
developed.Bioinorganic Chemistry and Applications 11
A new generation of scaﬀolds is needed with appropriate
porosity, degradation rates, and mechanical properties. New
processing techniques, namely, those that allow for the
development of scaﬀolds with improved mechanical prop-
erties without inﬂuencing the porosity and interconnectivity
should be studied and developed [46].
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